...
首页> 外文期刊>Stem cells international >Efficient One-Step Induction of Human Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) Produces MSC-Derived Neurospheres (MSC-NS) with Unique Transcriptional Profile and Enhanced Neurogenic and Angiogenic Secretomes
【24h】

Efficient One-Step Induction of Human Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) Produces MSC-Derived Neurospheres (MSC-NS) with Unique Transcriptional Profile and Enhanced Neurogenic and Angiogenic Secretomes

机译:有效的一步诱导人脐带衍生的间充质干细胞(UC-MSCs)产生MSC衍生的神经球(MSC-NS),具有独特的转录谱和增强的神经源性和血管生成分泌物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Cell therapy has emerged as a promising strategy for treating neurological diseases such as stroke, spinal cord injury, and various neurodegenerative diseases, but both embryonic neural stem cells and human induced Pluripotent Stem Cell- (iPSC-) derived neural stem cells have major limitations which restrict their broad use in these diseases. We want to find a one-step induction method to transdifferentiate the more easily accessible Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) into neural stem/progenitor cells suitable for cell therapy purposes. In this study, UC-MSCs were induced to form neurospheres under a serum-free suspension culture with Epidermal Growth Factor- (EGF-) and basic Fibroblast Growth Factor- (bFGF-) containing medium within 12 hours. These MSC-derived neurospheres can self-renew to form secondary neurospheres and can be readily induced to become neurons and glial cells. Real-time PCR showed significantly upregulated expression of multiple stemness and neurogenic genes after induction. RNA transcriptional profiling study showed that UC-MSC-derived neurospheres had a unique transcriptional profile of their own, with features of both UC-MSCs and neural stem cells. RayBio human growth factor cytokine array analysis showed significantly upregulated expression levels of multiple neurogenic and angiogenic growth factors, skewing toward a neural stem cell phenotype. Thus, we believe that these UC-MSC-derived neurospheres have amenable features of both MSCs and neural stem/progenitor cells and have great potential in future stem cell transplantation clinical trials targeting neurological disorders.
机译:细胞疗法已成为治疗中风,脊髓损伤和各种神经退行性疾病的神经疾病的有希望的策略,但胚胎神经干细胞和人诱导的多能干细胞 - (IPSC-)衍生的神经干细胞具有主要限制限制他们广泛使用这些疾病。我们想发现一种单步诱导方法,将更容易可接近的脐带衍生的间充质干细胞(UC-MSCs)转化为适于细胞疗法目的的神经茎/祖细胞。在该研究中,诱导UC-MSCs在无血清悬浮培养物下形成神经球,其在12小时内与表皮生长因子 - (EGF-)和含培养基的碱性成纤维细胞生长因子 - (BFGF-)。这些MSC衍生的神经球体可以自我更新以形成二级神经球,并且可以容易地诱导成为神经元和胶质细胞。实时PCR在诱导后显着上调了多个茎和神经源性基因的表达。 RNA转录分析研究表明,UC-MSC衍生的神经球有自己的独特转录曲线,具有UC-MSC和神经干细胞的特征。 Raybio人体生长因子细胞因子阵列分析显示出多种神经发生和血管生成生长因子的显着上调表达水平,朝向神经干细胞表型偏斜。因此,我们认为这些UC-MSC衍生的神经球体具有MSC和神经茎/祖细胞的可均可特征,并且在未来的干细胞移植临床试验中具有巨大的潜力靶向神经疾病。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号